Investigational Site Number :2760003

Münster 48155

1 studies enrolling now · 5 studies all time

What they study most

Alopecia Areata, Breast Cancer, Chronic Kidney Diseases, Heart Failure, Polyneuropathy, Inflammatory Demyelinating, Chronic, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

Studies at this site

• Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP — Enrolling by invitation
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata — Stopped early
• Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer — Stopped early
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early
• Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus — Completed